Exosomal RNAs in the development and treatment of pituitary adenomas

Mengqi Chang1,2, Shenzhong Jiang1, Xiaopeng Guo1

  • 1Department of Neurosurgery, China Pituitary Disease Registry Center, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.

Insights

Exosomes, small vesicles carrying RNAs, show promise in diagnosing and treating pituitary adenomas (PA). Specific exosomal RNAs can serve as early biomarkers for non-functioning PAs and indicators of tumor invasion.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Exosomes are extracellular vesicles involved in cell communication and drug delivery.
  • Pituitary adenomas (PA) are common central nervous system tumors with significant impact on quality of life.
  • The role of exosomes in PA development and hormone secretion is under-explored.

Purpose of the Study:

  • To review the impact of exosomal RNAs on pituitary adenomas (PA).
  • To explore the potential of exosomal contents as diagnostic biomarkers and therapeutic targets for PA.
  • To summarize current understanding of exosome mechanisms in PA.

Main Methods:

  • Literature review of studies on exosomes and pituitary adenomas.
  • Analysis of identified exosomal microRNAs, protein transcripts, and long noncoding RNAs.
  • Synthesis of findings related to exosomal roles in PA diagnosis and therapy.

Main Results:

  • Exosomal microRNA hsa-miR-1180-3p identified as a potential early biomarker for non-functioning pituitary adenomas (NFPAs).
  • Exosomal protein transcripts (MMP1, N-cadherin, CDK6, RHOU, INSM1, RASSF10) suggested as potential invasive biomarkers.
  • Exosomal hsa-miR-21-5p linked to distant bone formation in growth hormone-secreting PA (GHPA).
  • Tumor suppressors like lncRNA H19, miR-149-5p, miR-99a-3p, and miR-423-5p identified as potential therapeutic targets.

Conclusions:

  • Exosomal RNAs play significant roles in pituitary adenoma development and progression.
  • Exosomes offer promising avenues for early diagnosis and targeted therapy of pituitary adenomas.
  • Further research into exosome-mediated mechanisms can advance PA clinical management.

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.4K
Regulated mRNA Transport02:22

Regulated mRNA Transport

In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
6.3K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
22.9K